Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2Other solid neoplasm 2

Conditions

Mesothelioma 2Solid Tumors 1Solid Tumor, Adult 1Solid Tumor 1Retinoblastoma 1Pseudomyxoma Peritonei 1Mesothelioma, Malignant 1Lung Diseases 1Hematopoietic and Lymphatic System Neoplasm 1Colonic Neoplasms 1Childhood Solid Tumor 1Carcinoma, Ovarian Epithelial 1Appendiceal Neoplasms 1Advanced Cancers 1Advanced Cancer 1

Interventions

Pemetrexed 40Cisplatin 35pembrolizumab 21Nivolumab 17Carboplatin 16Ipilimumab 13Gemcitabine 10Cyclophosphamide 9fludarabine 6durvalumab 6Bevacizumab 6Radiotherapy, Intensity-Modulated 4LMB-100 4Drug Therapy 4Dexamethasone 4tremelimumab 3tazemetostat 3spartalizumab 3olaparib 3niraparib 3atezolizumab 3anetumab ravtansine 3amatuximab 3Vinorelbine 3Paclitaxel 3Oxaliplatin 3Imatinib Mesylate 3Fluorouracil 3Cerebral Decortication 3Blood Specimen Collection 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Mesothelioma × Surveys and Questionnaires × Other solid neoplasm × Clear all
NCT01356251 2023-02-08

Psychosocial Needs and Exploration of Online Support for Patients With Mesothelioma

Memorial Sloan Kettering Cancer Center

Phase NA Completed
107 enrolled
Other solid neoplasmThoracic

Mesothelioma

NCT02511600 2015-12-15

Comparison of Progel Sealant to Standard of Care (SOC) for Patients Undergoing Decortication

M.D. Anderson Cancer Center

Phase 3 Withdrawn
Other solid neoplasmThoracic

Lung Diseases, Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡